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EgyptAbstract Background: The available literature on minimally invasive colorectal cancer demon-
strates that laparoscopic approach is feasible and associated with better short term outcomes than
open surgery while maintaining equivalent oncologic safety. Reports have shown that robotic sur-
gery may overcome some of the pitfalls of laparoscopic intervention.
Objective of the work: To evaluate early results of robotic colorectal surgery, in a cohort of Egyp-
tian patients, regarding operative time, operative and early post-operative complications, hospital
stay and pathological results.
Patients and methods: A case series study which was carried out in surgical department at National
Cancer Institute, Cairo University. Ten Egyptian cases of colorectal cancer (age ranged from 30 to
67, 5 males and 5 females) were recruited from the period of April 2013 to April 2014. Robotic sur-
gery was performed to all cases.
Results: Three patients had low anterior resection, three anterior resection, one total proctectomy,
one abdominoperineal resection, one left hemicolectomy and one colostomy. The study reported no
mortalities and two morbidities. The mean operative time was 333 min. The conversion to open was
done in only one patient. A total mesorectal excision with negative circumferential margin was
accomplished in all patients, distal margin was positive in one patient. Mean lymph nodes removed
was 10.7. Mean hospital stay was 7.4 days.
Conclusion: To the best of our knowledge, this is the first study reporting the outcomes of robotic
colorectal cancer intervention in Egyptian patients. Our preliminary results suggest that robotic-
assisted surgery for colorectal cancer can be carried out safely and according to oncological prin-
ciples.
 2016 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The most important advance in rectal surgery over the last
30 years was development of total mesorectal excision
(TME). TME is associated with reduction of local recurrence
rate to less than 10% and improve survival [1].
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orectal disease began with first report of laparoscopic assisted
colectomy in 1991 [2]. The available literature on minimally
invasive TME for rectal cancer demonstrates that laparoscopic
TME is feasible and associated with better short term
outcomes than open surgery while maintaining equivalent
oncologic safety [3]. The proposed advantages of minimally
invasive colorectal surgeries (MIC) over open colectomies
include improved intra operative visualization of pelvis, less
stress on patient, less post-operative pain, improved cosmoses,
shorter duration of ileus and briefer hospitalization [4].
More recently, robotic assisted laparoscopic colorectal
surgery has become an intriguing technique most beneficial
for procedures requiring rectal resection. This technology
provides visualization and reach for these complex pelvic
procedures [5]. The 1st robotic assisted colorectal resection
was reported in Japan by Hashizume et al. in 2002 [6].
The use of robotics for the treatment of rectal cancer has
recently been shown to be feasible [7–10]. The general advan-
tages of the Da Vinci robotic system are a three-dimensional
view, hand-tremor filtering, fine dexterity, and motion scaling,
providing an absolute benefit when the operative field is
narrow and fixed and sharp dissection is necessary [11].
There are no available data on the outcome of robotic inter-
vention in cancer surgery in developing countries and the only
data available are those of American, European and Asian
experiences.
Within this context, the present study aims to report our
initial experience with robotic colorectal surgery in a series
of 10 consecutive Egyptian patients, regarding operative time,
operative & early post-operative complications, hospital stay
and pathological results.
Patients and methods
A case series study included 10 cases of colorectal cancer.
Patients were recruited from the surgical department of the
National Cancer Institute, Cairo University and operated by
Robot da Vinci Si Surgical System (Intuitive Surgical, USA)
over a period of one year. Their age ranged from 30 to
67 years. They were 5 males and 5 females. The patients
provided informed consent. Patients with previous laparo-
tomy, patients presented with intestinal obstruction, patients
with severe cardiac or pulmonary disease were excluded from
robotic surgery. The study was approved by local ethics
committee.
All rectal cancer patients with T3d, T3c, T4, N2, obturator,
internal iliac, presacral lymph nodes and extensive intravascu-
lar mural invasion were subjected to long course preoperative
neoadjuvant chemo-irradiation. Accordingly five patients
received preoperative neoadjuvant treatment.
Patient demographics, pathological, operative and
perioperative outcomes were recorded prospectively into our
departmental database and analyzed.
Surgical technique
For tumors of the upper rectum, a partial mesorectal excision
(PMSE) is done and for tumors of the mid and low rectum,
total mesorectal resection was done (TME). In cases of very
low tumors without invasion to the rectal sphincters, inter-sphincteric or total proctectomy resection with specimen
extraction through the anus and hand sewn coloanal anasto-
mosis was performed. Abdominoperineal resection (APR)
was proposed to patients with sphincter invading lesions or
with very low tumors.
Full robotic technique was done in all cases. The operation
was carried out with the aid of the four-arm Da Vinci robotic
system. The patient was placed in a modified lithotomy posi-
tion and then tilted into a steep Trendelenburg position with
the left side maximally elevated. The Da Vinci system is
docked (Fig. 1) coming in over the patient’s left hip at an acute
angle of about 30 in relation to the operating table. The two
working ports were placed 12–14 cm from symphysis pubis in
midclavicular line (Fig. 2). The two working arms usually
carry a grasper on the left connected to bipolar cautery and
hook with monopolar cautery on the right. The third robotic
arm on the patient left side carries another grasper and is used
for additional retraction. Medial to lateral mobilization with
high ligation of inferior mesenteric artery (IMA) and vein
(IMV) was carried out with clips (Figs. 3 and 4), then dissec-
tion continue in retroperitoneal space dropping the left ureter
and left gonadal vessels. Mobilization of splenic flexure is done
if needed. After completion of colon mobilization, dividing the
peritoneum in front of sacral promontory going in the retro
rectal space, then dissection continues circumferentially along
the mesorectal fascia down to the planned rectal section line.
Arms two and three, under control of the surgeon‘s left
hand are used for dissection and retraction of the bladder or
rectum as needed (Figs. 5 and 6).
Once the distal transection cut is prepared the assistant
divides the distal rectum using articulating linear stapler
through a 12 mm laparoscopic port inserted in the right lower
quadrant (Fig. 7).
Delivery of the specimen through Pfannenstiel incision,
dividing the proximal sigmoid at the proper distance, then
introduction of the anvil of EEA (end to end anastomosis
circular stapler), then purse string suture is done at the cut
end (Fig. 8). Creating pneumoperitoneum again and end to
end anastomosis was done using a EEA (Fig. 9).Results
A total of 10 patients underwent robotic colorectal resections.
patient clinical data are listed in Table 1. Mean age for patients
was 47.4 years (range 30–67), equal number of male and
female patients were involved. The patient BMI ranges from
24.8 to 39.5 with median 29.21. All patients presented with
bleeding per rectum, 6 patients (60%) presented with rectal
mass and 3 cases (30%) presented with change in bowel habits.
Regarding tumor location, most patients (60%) had tumors in
the lower rectum (<7 cm), upper rectum tumors were in 3
patients (30%) and one patient (10%) presented with tumor
in the descending colon.
The histopathologic data are presented in Table 2. Distal
margin was positive in one patient (10%), circumferential mar-
gin was negative in all cases. Half of patients (50%) were stage
II, 3 cases were stage I (30%), while 2 patients were stage III.
Mean distal margin was 4.6 cm (range 0–15) and mean number
of lymph nodes removed was 10.7 (range 5–23).
Regarding operative data; one patient (10%) was estimated
to be inoperable, 3 patients (30%) underwent low anterior
Figure 1 Port placement.
Figure 2 Docking.
Figure 3 IMA is skeletonized at its origin.
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resection (30%). One patient (10%) had total proctocolectomy
and coloanal anastomosis, and one (10%) had Lt hemicolec-
tomy and abdominoperineal resection. The remaining one case
(10%) underwent colostomy for locally advanced rectal cancer
(T4) post neoadjuvant RTH and CTH, the tumor was fixed to
the sacrum. Means for docking and robotic times were39.5 min (range 30–50) and 4.9 h (range 3–7) respectively.
The mean total operative time was 333 min (range 215–465).
Estimated blood loss ranged from 200 to 500 cc (mean
340 cc). The mean hospital stay was 7.4 days (range 5–16)
(Table 3).
Considering morbidity and mortality, the study showed no
mortalities or intraoperative bleeding (>1000 cc blood loss).
Only one case (10%) needs reoperation and 2 cases (20%)
had prolonged post-operative ileus (Table 4).
Discussion
Proponents of the robotic technique claim that endowristed
robotic instruments allow a surgeon to approach the rectum
from different directions and angles, thus permitting precise
retraction and sharp dissection [12].
Figure 4 IMV is ligated with clips.
Figure 5 Posterior dissection.
Figure 6 Anterior dissection.
Figure 7 Rectal transection using articulating linear stapler.
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consecutive Egyptian rectal cancer cases performed at the
National Cancer Institute, Cairo University. Prolonged opera-
tive time is often described as one of the major drawbacks of
robotic surgery. Our study reported a mean operative time
of 333 min, this time compared favorably to previous studies
done by Spinoglio et al. and Sawada et al. [13,14] which
reported a mean operative time of 383.3 min, and 417 min
respectively. However other studies reported a shorter time
of operation [9,14]. This difference is mainly due to the less
experience attributed to the novelty of the procedure in our
country.
Most authors reported a very low conversion rate for
robotic colorectal operations [15–17]. This goes in accordance
with our study which reported only one case (10%) which was
converted to open. The reason behind this conversion in our
case was mainly due to that the tumor was locally advanced
and when converted to open procedure, the tumor was irre-
sectable and only colostomy was done.Owing to the precise dissection and to the significant mag-
nification, the blood loss in our study ranged between 200 and
500 cc. All studies reported the same results of blood loss not
exceeding the 500 cc [9,18]. This indicates that the blood loss
was significantly lower for robotic surgeries than laparoscopic
surgeries and thus may reduce the probability of transfusion.
There was no occurrence of anastomotic leak in our study;
however Pigazzi et al. reported a 10.5% leak [19]. We can refer
this discrepancy to the fact that we always perform protective
ileostomy in low anastomosis. Only one case needed reopera-
tion (10%) which goes in agreement with percentage (10.4%)
of a study done by Hellan et al. [16]. Two patients (20%)
had prolonged postoperative ileus. This stands in contrast to
studies done by Pigazzi et al. [19] and Hellan et al. [16], which
reported lower percentage of prolonged ileus >6 days. This
may be explained by many factors as the prolonged operative
time in our cases and lack of routinely epidural analgesia.
Figure 8 Extracorporeal anvil insertion and purse string
suturing.
Figure 9 End to end anastomosis using a circular stapler.
Table 1 Clinical presentation of patients.
Variable Number of patients (%)
Bleeding per rectum 10 (100%)
Rectal mass 6 (60%)
Change in bowel habits 3 (30%)
Tumor location
Upper rectum (>11 cm) 3 (30%)
Left colon 1 (10%)
Lower rectum (<7 cm) 6 (60%)
Table 2 Histopathological data.
Variable Percentage/range
Stage I 3 (30%)
Stage II 5 (50%)
Stage III 2 (20%)
Number of removed LN 10.7 (5–23)
Distal margin (cm) 4.6 (0–15)
Positive circumferential margin 0
Positive distal margin 1 (10%)
Table 3 Operative data.
Variable Percentage/range
Type of operation
Low anterior resection 3 (30%)
Total proctectomy & colo-anal anastomosis 1 (10%)
APR 1 (10%)
Anterior resection 3 (30%)
Lt hemicoloctomy 1 (10%)
Colostomy 1 (10%)
Docking time (minutes) 39.5 (30–50)
Robotic time (hours) 4.9 (3–7)
Total operative time (min) 333 (215–480)
Blood loss (cc) 340 (300–500)
Hospital stay (days) 7.4 (5–16)
Conversion to open 1 (10%)
Table 4 Morbidity and mortality.
Variable Number of
patients (%)
Intraoperative bleeding (more than 1000 cc) 0
Re-operation 1 (10%)
Postoperative ileus 2 (20%)
Mortality 0
Results of robotic colorectal surgery at the National Cancer Institute 173In our study, the mean hospital stay was 7 days, which is
comparable to that of the Pigazzi et al. study (8.3 days) [19].
In terms of oncologic outcome, the distal margin clearance
was obtained in all our cases except for one patient. The mean
number of harvested lymph nodes was 10.7 in our study which
was to some extent less than that of open and laparoscopic ser-
ies [18] and other robotic studies. The Pigazzi et al. study [19]reported mean lymph nodes of 14.1, and in Hellan et al. and
Luca et al. studies, the mean harvest was 13 and 18.5 respec-
tively [16,17].
As observed by other authors, we agree that Da Vinci sys-
tem facilitates nerve sparing TME [20,21]. Robotic TME seems
to enhance microdissection accuracy, leading to better, safer
and more comfortable mesorectal dissection with a lower risk
of positive CRM.
The disadvantage of the use of Robotics in colorectal sur-
gery has been paid to the high cost that is associated with this
technique. Several studies have reported that the cost of
robotic colorectal surgery is higher than that of laparoscopic
surgery [22,23]. This fact stand behind the limitation of its
widespread application in many countries [24]. Comparing
laparoscopic colorectal surgery to robotic colorectal surgery
is beyond the scope of this study, however laparoscopic sur-
gery has a steep learning curve especially for rectal cancer,
where the integrity of total mesorectal excision (TME) influ-
ences outcomes, one of potential benefits of robotic surgery
is to facilitate less experienced surgeons to perform minimal
axis surgery [25–27].
174 A.S. Zaghloul, A.M. MahmoudHence, future studies should assess the cost-effectiveness of
robotic colorectal surgeries based on long term oncologic
outcomes and functional results.
Our impression in the studied group is that the maximum
benefit of robotic colorectal surgery is in lower rectal tumors,
that is to overcome the constrains of narrow pelvic space for
adequate total mesorectal excision, and to precisely dissect
and protect autonomic pelvic nerves for preservation of
potency and continence.
On the other hand, we cannot ignore the great advantages
of the technique itself where a console operator can use three
working arms with articulated instruments and stable control-
lable camera plate form, in addition to a skilled assistant with
two assistant trocars, that is to say five working trocars or five
hands with unlimited advantage of accurate and magnified
oncologically safe dissection.
Conclusion
Robotic colorectal surgery is safe and applicable approach in
our patients. Colorectal cancer surgeons who lack extensive
laparoscopic experience and wish to perform a transition from
open to minimally invasive surgery may benefit from this
modality. Future studies are necessary to assess the long term
oncological outcomes of the robotic colorectal surgery in com-
parison with open and laparoscopic procedures and thereafter
determine the feasibility of its widespread application.
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